Načítá se...
Targeted Therapies in Hematology and Their Impact on Patient Care: Chronic and Acute Myeloid Leukemia
Advances in the genetic and molecular characterizations of leukemias have enhanced our capabilities to develop targeted therapies. The most dramatic examples of targeted therapy in cancer to date are the use of targeted BCR-ABL protein tyrosine kinase inhibitors (TKI) which has revolutionized the tr...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4098770/ https://ncbi.nlm.nih.gov/pubmed/24246694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2013.09.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|